Systemic treatment of adult patients with acute lymphoblastic leukemia continues to evolve with the introduction of targeted and T-cell activating therapies, bu
Program: Oral and Poster Abstracts Type: Oral Session: 615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Improving Intensive Chemotherapy Regimens for…
BTKi in Treatment Of Chronic Lymphocytic Leukemia – Download as a PDF or view online for free
IntroductionLiv.52® is a multi-herbal marketed on advertised claims for various liver diseases. However, there is a lack of high-quality clinical evidence supporting its use. A…
Dr. Nitin Jain A/Professor Department of Leukaemia MD Anderson Cancer Center Houston, Texas,
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile,…
Key Points. Using whole-genome sequencing and RNA-seq, we characterized the genomic landscape of 295 DS-ALL cases and identified 15 distinct subtypes.DS-ALL exh
Children with Down syndrome (DS) have a 20 times higher risk of developing acute lymphoblastic leukemia (DS-ALL). In this issue of Blood, Li et al1 report…
Key Points. Non-Restrictive diet is non-inferior to traditional Protective diet during neutropenia after HSCT.In multivariable analysis, multiple myeloma diagno
Key Points. Non-Restrictive diet is non-inferior to traditional Protective diet during neutropenia after HSCT.In multivariable analysis, multiple myeloma diagno
